The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bracketing and Matrixing Designs for Stability Testing of New Drug Substances and Products
(2009) · Handbook of Pharmaceutical Manufacturing Formulations · doi:10.3109/9781420081244-13 · Cited by 1,313
Lipid-Based Delivery Systems and Intestinal Lymphatic Drug Transport: A Mechanistic Update
Trevaskis, N. L., Charman, W. N., & Porter, C. J. H. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.007 · Cited by 442
Lipid Nanoparticles with a Solid Matrix (SLN®, NLC®, LDC®) for Oral Drug Delivery
Muchow, M., Maincent, P., & Müller, R. H. (2008) · Drug Development and Industrial Pharmacy · doi:10.1080/03639040802130061 · Cited by 394
Manjunath, K., & Venkateswarlu, V. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.06.006 · Cited by 380
Lipid-based formulations for intestinal lymphatic delivery
O’Driscoll, C. M. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00051-9 · Cited by 372
Oral bioavailability of cyclosporine: Solid lipid nanoparticles (SLN®) versus drug nanocrystals
Müller, R. H., Runge, S., Ravelli, V., Mehnert, W., Thünemann, A. F., & Souto, E. B. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.02.045 · Cited by 304
Self-citationPaliwal, R., Rai, S., Vaidya, B., Khatri, K., Goyal, A. K., Mishra, N., Mehta, A., & Vyas, S. P. (2009) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2008.08.003 · Cited by 288
Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs
Hu, L., Tang, X., & Cui, F. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357044959 · Cited by 281
MULLER, R. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.07.006 · Cited by 199
Macal, M., Sankaran, S., Chun, T.-W., Reay, E., Flamm, J., Prindiville, T. J., & Dandekar, S. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.35 · Cited by 195
Cited by
A brief review on solid lipid nanoparticles: part and parcel of contemporary drug delivery systems
Duan, Y., Dhar, A., Patel, C., Khimani, M., Neogi, S., Sharma, P., Siva Kumar, N., & Vekariya, R. L. (2020) · RSC Advances · doi:10.1039/d0ra03491f · Cited by 614
Ganesan, P., & Narayanasamy, D. (2017) · Sustainable Chemistry and Pharmacy · doi:10.1016/j.scp.2017.07.002 · Cited by 434
BCS class IV drugs: Highly notorious candidates for formulation development
Ghadi, R., & Dand, N. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.014 · Cited by 361
Modi, S., & Anderson, B. D. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400154a · Cited by 307
Solid lipid nanoparticles: an oral bioavailability enhancer vehicle
Harde, H., Das, M., & Jain, S. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.604311 · Cited by 281
Metadata
- Authors
- Aji Alex, M. R., Chacko, A. J., Jose, S., & Souto, E. B.
- Venue
- European Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2011-01
- Volume
- 42
- Issue
- 1-2
- Pages
- 11-18
- ISSN
- 0928-0987 (ISSN-L)
- OpenAlex
- W2081926138
- Cited by
- 258
- References
- 21
- FWCI
- 7.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting. https://app.cochat.ai/papers/10.1016/j.ejps.2010.10.002
- The paper
- Aji Alex, M. R., Chacko, A. J., Jose, S., & Souto, E. B. (2011). Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting. European Journal of Pharmaceutical Sciences. https://doi.org/10.1016/j.ejps.2010.10.002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.